15-20534471-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145004.2(GOLGA6L6):c.1963G>A(p.Glu655Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000247 in 1,459,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145004.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GOLGA6L6 | NM_001145004.2 | c.1963G>A | p.Glu655Lys | missense_variant | 8/9 | ENST00000619213.1 | NP_001138476.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GOLGA6L6 | ENST00000619213.1 | c.1963G>A | p.Glu655Lys | missense_variant | 8/9 | 5 | NM_001145004.2 | ENSP00000480376.1 |
Frequencies
GnomAD3 genomes AF: 0.00000701 AC: 1AN: 142574Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000138 AC: 2AN: 144954Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 77308
GnomAD4 exome AF: 0.0000266 AC: 35AN: 1317002Hom.: 0 Cov.: 35 AF XY: 0.0000200 AC XY: 13AN XY: 649316
GnomAD4 genome AF: 0.00000701 AC: 1AN: 142574Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 69576
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.2041G>A (p.E681K) alteration is located in exon 8 (coding exon 8) of the GOLGA6L6 gene. This alteration results from a G to A substitution at nucleotide position 2041, causing the glutamic acid (E) at amino acid position 681 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at